These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 9707352

  • 1. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study.
    Terziivanov D, Atanasova I, Dimitrova V.
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):376-82. PubMed ID: 9707352
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D, Atanasova I, Dimitrova V, Robeva R, Unger S, Mück W.
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ, Beringer PM, Aminimanizani A, Louie SG, Shapiro BJ, Jelliffe R, Gill MA.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [Abstract] [Full Text] [Related]

  • 4. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P, Gastonguay MR.
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [Abstract] [Full Text] [Related]

  • 6. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
    Khan MK, Khan MF.
    Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX, Jiang ZG, Ding HZ, Liu YH.
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [Abstract] [Full Text] [Related]

  • 8. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A, Bellini P, Terracini B, Italian MISA Group.
    Epidemiol Prev; 2001 Jun; 25(2 Suppl):1-71. PubMed ID: 11515188
    [Abstract] [Full Text] [Related]

  • 9. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P, Cremers SC, den Hartigh J, Rijnbeek EM, Ringers J, Lamers CB, van Hoek B.
    Aliment Pharmacol Ther; 2005 Mar 01; 21(5):549-57. PubMed ID: 15740538
    [Abstract] [Full Text] [Related]

  • 10. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
    Overholser BR, Kays MB, Forrest A, Sowinski KM.
    J Clin Pharmacol; 2004 Sep 01; 44(9):1012-22. PubMed ID: 15317829
    [Abstract] [Full Text] [Related]

  • 11. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
    Bondareva IB, Jelliffe RW, Sokolov AV, Tischenkova IF.
    J Clin Pharm Ther; 2004 Apr 01; 29(2):105-20. PubMed ID: 15068399
    [Abstract] [Full Text] [Related]

  • 12. Prospective validation of an optimal sparse plasma-sampling strategy for estimating ciprofloxacin pharmacokinetics.
    Amsden GW, Ballow CH.
    Pharmacotherapy; 1996 Apr 01; 16(5):937-41. PubMed ID: 8888090
    [Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetic modelling of tramadol with application of the NPEM algorithms.
    Gan SH, Ismail R, Wan Adnan WA, Zulmi W, Jelliffe RW.
    J Clin Pharm Ther; 2004 Oct 01; 29(5):455-63. PubMed ID: 15482390
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA, Kreil VE, Landoni MF.
    J Vet Pharmacol Ther; 2004 Jun 01; 27(3):155-62. PubMed ID: 15189301
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A, Martínez-Larrañaga MR, Díaz MJ, Fernández-Cruz ML, Martínez MA, Frejo MT, Martínez M, Iturbe J, Tafur M.
    Am J Vet Res; 1999 Nov 01; 60(11):1377-82. PubMed ID: 10566812
    [Abstract] [Full Text] [Related]

  • 16. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE, Tett SE.
    Eur J Clin Pharmacol; 2002 Dec 01; 58(9):597-605. PubMed ID: 12483452
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A, Martínez-Larrañaga MR, Iturbe J, Martínez MA, Díaz MJ, Frejo MT, Martínez M.
    Res Vet Sci; 2001 Oct 01; 71(2):101-9. PubMed ID: 11883887
    [Abstract] [Full Text] [Related]

  • 18. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S, Saint-Marcoux F, Rousseau A, Zhang D, Leroy V, Marquet P, Jacqz-Aigrain E.
    Ther Drug Monit; 2007 Feb 01; 29(1):96-102. PubMed ID: 17304156
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS, Ramesh S, Ahmad AH, Tripathi HC, Sharma LD, Malik JK.
    Vet J; 2002 Jan 01; 163(1):85-93. PubMed ID: 11749141
    [Abstract] [Full Text] [Related]

  • 20. Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.
    Bos AM, Boom K, Vinks AA, Boezen HM, Wanders J, Dombernovsky P, Aamdal S, de Vries EG, Uges DR.
    Cancer Chemother Pharmacol; 2004 Jul 01; 54(1):64-70. PubMed ID: 15069581
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.